Mitral annular calcification (MAC) is a common condition in which calcium deposits accumulate around the heart's mitral valve. It is a degenerative process that is seen in elderly patients, and is often associated with cardiovascular disease. It can lead to a number of health problems, including an increased risk of stroke, heart attack, and heart failure. In this article, we will explore the impact of MAC on heart health, and discuss how it can be managed.
Mitral annular calcification is a condition in which calcium deposits accumulate around the heart's mitral valve. It is a degenerative process that is seen in elderly patients, and is often associated with cardiovascular disease. The mitral valve is a one-way valve that prevents blood from flowing backwards into the left atrium. When calcium builds up around the valve, it can cause it to become stiff and narrow, making it difficult for the valve to open and close properly. This can lead to a number of health problems, including an increased risk of stroke, heart attack, and heart failure.
There are several risk factors that may increase the likelihood of developing MAC. These include: • Age: MAC is more common in older individuals, and the risk increases with age. • Gender: Women are more likely to develop MAC than men. • Hypertension: High blood pressure can increase the risk of developing MAC. • Diabetes: People with diabetes are more likely to develop MAC. • Smoking: Smokers are more likely to develop MAC than non-smokers. • Family history: Having a family history of MAC may increase the risk. • Diet: A diet high in saturated fats and low in calcium and vitamin D can increase the risk of MAC.
The symptoms of MAC vary from person to person, but can include: • Shortness of breath • Fatigue • Palpitations • Chest pain • Swelling of the feet and ankles • Dizziness or fainting • Irregular heartbeat
The diagnosis of MAC is typically made using echocardiography, a type of ultrasound that uses soundwaves to create images of the heart. Other tests, such as a chest X-ray, electrocardiogram, or cardiac catheterization, may also be used to diagnose MAC.
The treatment of MAC depends on the severity of the condition. In some cases, lifestyle changes, such as quitting smoking, controlling blood pressure, and eating a healthy diet, may be enough to manage the condition. In more severe cases, medications, such as diuretics, ACE inhibitors, and beta blockers, may be prescribed to reduce the risk of complications. In some cases, surgery may be necessary to repair or replace the mitral valve.
Mitral annular calcification is a common condition in which calcium deposits accumulate around the heart's mitral valve. It is a degenerative process that is seen in elderly patients, and is often associated with cardiovascular disease. It can lead to a number of health problems, including an increased risk of stroke, heart attack, and heart failure. The risk factors, symptoms, diagnosis, and treatment of MAC will vary from person to person, but it is important to be aware of the condition and take steps to manage it.
1.
Glioblastoma treatment breakthrough shows promise
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Study suggests exercise could reduce breast cancer recurrence
4.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
5.
Daily physical activity, even at light intensities, linked to lower cancer risk
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
3.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
4.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation